LANTHEUS HOLDINGS INC. - COMMON STOCK

Lantheus Welcomes CMS’ Proposed CY25 Rule for Improved Payment for Specialized Diagnostic Radiopharmaceuticals to Support Patient Access

10 Jul 2024 12:32:21 By Nasdaq GlobeNewswire

NetDania - New 12 months High: LANTHEUS HOLDINGS INC. - COMMON STOCK

10 Jul 2024 09:45:28 By NetDania Notify

Lantheus Appoints Jamie Spaeth as Chief People Officer

08 Jul 2024 08:30:00 By Nasdaq GlobeNewswire

Lantheus Acquires Global Rights to Life Molecular Imaging’s Novel Therapeutic and Diagnostic Pair Targeting GRPR for Prostate and Breast Cancers

27 Jun 2024 07:05:00 By Nasdaq GlobeNewswire

Lantheus’ AI-Enabled aPROMISE Now Available on Siemens Healthineers’ syngo.via platform

03 Jun 2024 08:30:00 By Nasdaq GlobeNewswire

Lantheus to Present at the William Blair 44th Annual Growth Stock Conference

28 May 2024 08:00:00 By Nasdaq GlobeNewswire

Lantheus Announces Executive Appointments to Accelerate Innovation

15 May 2024 16:30:00 By Nasdaq GlobeNewswire

Lantheus Reports First Quarter 2024 Financial Results

02 May 2024 07:00:01 By Nasdaq GlobeNewswire

Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time

18 Apr 2024 08:00:00 By Nasdaq GlobeNewswire

Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024

05 Mar 2024 08:30:00 By Nasdaq GlobeNewswire

Lantheus Announces the FDA Approval of DEFINITY® (Perflutren Lipid Microsphere) for Pediatric Patients

04 Mar 2024 08:30:00 By Nasdaq GlobeNewswire

Lantheus Announces Promotion of Amanda Morgan to Chief Commercial Officer

28 Feb 2024 08:30:00 By Nasdaq GlobeNewswire

Lantheus to Present at the TD Cowen 44th Annual Health Care Conference

26 Feb 2024 08:30:00 By Nasdaq GlobeNewswire

Lantheus Reports Fourth Quarter and Full Year 2023 Financial Results

22 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

Lantheus Announces Collaboration to Provide Novel Tau Imaging Agent for Large Consortium Clinical Trial Sponsored by the National Institute on Aging

13 Feb 2024 08:30:00 By Nasdaq GlobeNewswire

Lantheus to Host Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast on February 22, 2024, at 8:00 a.m. Eastern Time

08 Feb 2024 08:00:00 By Nasdaq GlobeNewswire

Lantheus Announces CEO Succession Plan

23 Jan 2024 07:45:00 By Nasdaq GlobeNewswire

Lantheus Announces Acceptance of its First-to-File ANDA for Generic LUTATHERA® (Lutetium Lu 177 Dotatate)

11 Jan 2024 08:00:00 By Nasdaq GlobeNewswire

Lantheus Expands Radiopharmaceutical Oncology Pipeline via Strategic Agreements with Perspective Therapeutics

09 Jan 2024 08:00:00 By Nasdaq GlobeNewswire

Lantheus Reports Preliminary Fiscal Year 2023 Revenue

09 Jan 2024 07:55:00 By Nasdaq GlobeNewswire